Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity

https://easypdfshare.com/s/Oo6dAFimCL-B62CYrC6FC

Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity, preserving organ function during regeneration and limiting pathological remodeling.